Royal Society of Chemistry, New Journal of Chemistry, 11(46), p. 5078-5090, 2022
DOI: 10.1039/d1nj04816c
Full text: Unavailable
The pharmacophoric features of the novel series of 1,3,4-oxadiazole–oxoindole conjugates (IVa–g) as potential anti-SARS-CoV-2 agents based on the reported Mpro inhibitor (Ia) are presented.